RELATED CONTENT
NEWS
- Eisai mulls NICE appeal after another no for Halaven
- "Step change" Yervoy from BMS not cost effective for NICE: may need biomarker test
- Adverse effects cast doubt over Sanofi's Taxotere follow on Jevtana, says NICE
- NICE recommends reduced-impact Mepact from Takeda for bone cancer
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Interview: Adimab's Gerngross seeks two sweethearts
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here


